Solvay Pharma Россия и СНГ Обратная связь Карта сайта
Суббота, 27 декабря 2008 г.
Сделать стартовойДобавить в избранноеСообщить о странице другуW@PAvantGoPDA
В стремлении к прогрессу, с заботой о людях
Бетасерк
Регистрация
Бесплатный доступ к сайту
XV Российский национальный конгресс "Человек и лекарство"

Библиография

Включен в программу ОНЛС

  1. Вейс Г. Головокружение / В кн.: "Неврология" Под ред М Самуэльса М Практика, 1997 -С 94-120
  2. Верещагин Н.В. Недостаточность кровообращения в вертебральнобазилярной системе //Consihum Medicum -2001 -Приложение -С 13-17
  3. Гусев Е.И. , Никонов А. А. , Скворцова В. И. и др. Лечение головокружений препаратом Бетасерк у больных с сосудистыми и травматическими поражениями головного мозга // Журн неврол и психиатр -1998 -№11
  4. Кадымова М.И., Полякова Т.Е. , Владимирова Т.В. Применение Бетасерка у больных с кохлеовестибулярными нарушениями // Вести Оторинолар 1998, №5, С 4950
  5. Лавров А.Ю. Применение Бетасерка в неврологической практике // Неврол журн - 2001 - Т 6 - №2
  6. Морозова С.В. Зайцева О.В. Комплексный подход к лечению больных острой нейросенсорной тугоухостью сосудистого генеза // ЮжноРоссийский Мед журн -2001 -№1-2
  7. Патякина О.К. Лечебная тактика при вестибулогенном головокружении //Consihum Medicum -2001 -Приложение -С 9-12
  8. Шеремет А.С. Головокружение как признак поражения вестибулярного анализатора (диагностические стереотипы) // Consihum Medicum - 2001 - Приложение - С 3-8
  9. Шмидт Е.В., Лунев Д.К., Верещагин Н.В. Сосудистые поражения нервной системы М. Медицина, 1975-662 с
  10. Янчевски Г., Пьерхала К. Бетагестин в лечении головокружений // Польск Отоларингология (Otolaryngologia Polska) - 1995 -Vol XLIX(Suppl 19)
  11. Aantaa E. Treatment of acute vestibular vertigo //ActaOtolaryngol (Slockh ) -1991 -Vol (Suppl 479) - P 44-47
  12. Aantaa E., Skmhoj A. Controlled clinical trial comparing the effect of betahistme hydrochlonde and prochlorperazme maleate on patients with Meniere's disease//Ann Clm Res -1976 -Vol 8 - P 284-287
  13. Anderson W.D. , Kubicek W.G. Effects of betahistme hydrochlonde, nicotmic acid and histamme on basilar blood flow in anaesthetized dogs//Stroke -1971 -Vol 2 -P 409-415
  14. Arrang J.M., Garbarg M., Quach Т.Т. et al Actions of betahistme at histamme receptors in the brain // Eur J Pharmacol - 1985 - Vol 111 - P 73-84
  15. Arrang J., Garbarg M , Schwartz A Automhibition on brain histamme release mediated by a novel class (H3) of histamme receptor // Nature - 1983 - Vol 302 - P 9
  16. Arrang J M , Garbarg M , Schwartz J С Automhibition of brain histamme release mediated by a novel class (H3) of histamme receptor//Nature -1983 -Vol 302 -P 832-837
  17. Arrang J M , Garbarg M , Schwartz J С Automhibition of histamme synthesis mediated by presynaptic H3 receptors // Neuroscience -1987 -Vol 23 -P 149-157
  18. Bertrand R A Longterm evaluation of the treatment of Meniere's disease with betahistme HC1 //Adv Otorhmolaryngol - 1982 -Vol 28 -P 104-110
  19. Bertrand RA Meniere's disease subjective and objective evaluation of medical treatment with betahistme HCI Acta Otolaryngol 1972, (Suppl 305) 48-69
  20. Betts T, Harris D , Gadd E The effects of two antivertigo drugs (betahistme and prochlorperazme) on driving skills // Br J Clm Pharmacol -1991 -Vol 32 - P 455-458
  21. Betts T, Marcman D , Debenham S et al Effects of antyhistamme drugs on actual driving performance//Brit Med J -1984 -Vol 288 - P 281
  22. Blair R Medical management of vestibular dysfunction//ORL Clm N Amer - 1984 - Vol 17 - P 679
  23. Bolt G R , Verians M L Peridic Drug Safety Update Report Betahistin -01 04 1970 to 31 03 1995
  24. BrocklehurstJ С Prescribing for the elderly//Br Med J -1981 -Vol 283 - P 618
  25. Canty P, Valentine J , Papworth S J Betahistme in peripheral vertigo A doubleblmd, placebocontrolled, crossover study of Sere versus placebo//J Laryngol Otol -1981 -Vol 95 - P 687-692
  26. Chaplin S Drugmduced parkmsonism prescribing habits must change//Genatr Med - 1989, Feb -P 13-14
  27. Cochran К M , Allan J G , Russell R I A study of the effect of betahistme on gastric acid secretion in man//Curr Med Res Opm - 1974 -Vol 2 -P 63-66
  28. Colman В Н Meniere's disease / In Ballantyne J , Groves J , ScottBrown В "Diseases of the ear, nose and throat Part 2 The ear", 4th Ed - London, Butterworths, 1979 - P 785-835
  29. Committee on Mearmg and Eguilibnum
  30. Guidylmes for the diagnosis and evaluation of therapy in Menieres desease//Otolaryngol Head Neck Surg -1995-113-p 181-185
  31. Conraux С , Cellier D Chronic vertigo sensations//Impact Med -1988 -Vol 260
  32. Dale Н Н Adventures in physiology - London Pergamon Press, 1953
  33. Dale Н Н , Laidlaw PP The physiological action of/Simidazolylethy-lamme//J Physiol (Lond) -1910 -Vol 41 -P 318-344
  34. Deermg R В , Prescott P, Simmons R L , Downey L J A doubleblmd crossover study comparing betahistme and cmnarizme in the trealment of recurrent vertigo in patients in general practice // Curr Med Res Opm -1986 -Vol 10 (Suppl 4) -P 209-214
  35. Derlacki E The medical treatment of Meniere's disease // ORL Clm N Amer-1968 -Vol 1 -P519
  36. Dutia M В , Wang J J Effect of histamme and betahistme on rat medial vestibular nucleus neurones possible mechanism of action of antihistammeergic drugs in vertigo and motion sickness//Exp Brain Res -1995 -105 -P 18-24
  37. Elbaz P, TaillandierJ Clinical study on betahistme in vertigo of Meniere's disease Oto Rhino Laryngol 1975, 10 433-435
  38. Elia J С A new approach to the treatment of vertigo associated with Meniere's disease Angiology 1965, 16 464-469
  39. Elia J С Double-blind evaluation of a new treatment for Meniere's syndrome J Am Med Assoc 1966, 196 187-189
  40. Elia J С Long term treatment of MOniHre's disease Int Surg 1970, 53 24-27
  41. Elia J С Dizziness Presented as a scientific exhibit at the 114th annual convention of the American Medical Association - New York, June, 1965
  42. Esser R J E The prolem binding of betahistme - Data on file Report No 56630/49/77(1977)
  43. Fischer A J E M Histamme in the treatmenl of vertigo // Acta Otolaryngol (Stockh ) -1991 -Vol 479 (Suppl ) - P 24-28
  44. Fischer A J E M van Elferen L W M Betahistme in the treatment of paroxysmal attacks of vertigo a double blind trial // J Drug Ther Res -1985 -Vol 10 - P 9, 933-937
  45. Fujmo A , Tokumasu К , Yosio S , Naganuma H et al Vestibular training for benign, paroxysmal positional vertigo it's efficacy in comparison with antivertigo drugs//Arch Otolaryngol Head Neck Surg 1994 -120 - P 497-504
  46. Frew I J С , Menon G N Betahistme hydrochlonde in Meniere's disease//Postgrad Med J -1976 -Vol 52 -P 501-503
  47. Goodman L S , Oilman A (Eds) The pharmacological basis of therapeutics -NewYork Macmillan, 1980
  48. Grass PM Cerebral histamme Indications for neuronal and vescular regulation//J Cereb Blood Flow Metab -1982 -Vol 2 - P 3-23
  49. Gross PM Multiple actions of histamme on cerebral blood vessels// Adv BIOSCI -1985 -Vol 51 -P 341-349
  50. Gremer GF, Conraux С Collard M et al Treatment of vertigo in Meniere's disease with betahistme Rev Oto Neuro Ophthalmol 1975,47 227-236
  51. GuayRM Meniere's disease Appl Ther 1970, 12 25-27
  52. Guerner Y Meniere's disease and its treatment with betahistme dihydrochlonde Rev Med 1975, 23 1601-1608
  53. Jakobs R Martin G The therapy of tinnitus resulting from blast injury HNO 1978,26 104-106
  54. Hicks J J , Hicks J N , Cooley H N Meniere s disease // Arch Otolaryngol -1967 -Vol 86 - P 610-613, 620
  55. Hilger J Medical treatment of Meniere's disease / In "The Vestibular System and Its Disease R J Wolfson (Ed Philadelphia Univeersity of Pennsylvania Press, 1966
  56. Hmchclife R Review of treatment of Meniere's disease // Acta Otolarmgol (Stockh ) -1972 -Vol 305 -P 10
  57. HommesOR A study of the efficacy of betahistme in Meniere's syndrome ActaOtolaryngol 1972, (Suppl 305) 70-79
  58. Norton B.T. The clinical use of Beta2pyridylalkylamines. Part II. Treatment of histamme cephalgia (Norton's headache) with a note on angina pectoris // Proc. Mayo Clin. - 1962. - Vol. 37. - P. 713-723.
  59. Kirsten E.B., Sharma J.N. Microiontophoresis of acetylcholine, histamme and their antagonists on neurones in the medial and lateral vestibular nuclei of the cat// Neuropharmacology. - 1976. - P. 15. -P.743-753.
  60. Lacour M. Histamin. Vestibular function and vestibular compensation. - Elsevier: Paris, 1998.
  61. Laurikamen E.A., Miller J.M., Quirk W.S. etal. Betahistine induced vascular effects in the rat cochlea // Am. J. Otol. - 1993. - Vol. 14. - P. 24-30.
  62. Legent F. Essai therapeutique Sec versus placebo en double aveu-gle chez des patients souffrant de vertiges paroxystiques iteratifs // Le Concours Medical ORL. - 1988. - Vol. 29.
  63. Legent R, Calais D., Cellier D. Recurrent paroxysmal vertigo and Sere: controlled clinical trials // Concours. Med. - 1988. - Vol. 29.
  64. Le Pere DM. Evaluation of a new symptomatic treatment for Meniere's disease. Clin Med 1967; 74: 63-64
  65. Linn J.S. Systeme histammerqique central et etats de doctoral des Scmces, Universite Claude Bernard Lion I -1994. - P. 237.
  66. Marlowe F. Drug treatment of Meniere's disease // ORL Clin. N. Amer. - 1973.-Vol. 6.-P. 119.
  67. Martmez D.M. The effect of Sere (betahistme dihydrochlonde) on the circulation of the inner ear in experimental animals // Acta Otolaryngol. - 1972. -Vol. (Suppl. 305). - P. 29-46
  68. Martins J. New basis for control of Meniere's disease. Eye, Ear, Nose, Throat Dig 1968; 30 (2): 47-51
  69. Martins JK. Long term office treatment of Meniere's disease. Eye, Ear, Nose Throat Mon 1969; 48: 29-31
  70. Matsuoka I., Ito J., Takahashi H. et al. Experimental vestibular pharmacology: ammireview with special reference to neuroactive substances and antivertigo drugs//Acta Otolaryngol. (Stockh). - 1985.-Vol. 419 (Suppl.). - P. 62-70.
  71. Meyer J.S., Mathew N.T., HartmannA., Rivera V.M. Orally administered betahistme and regional cerebral blood flow in cerebrovascular disease //J. Clin. Pharmacol. - 1974. -Vol. 14. - P. 280.
  72. Miller J.M., Laurikamen E.A., Nuttall A.L. The vascular mechanism of action of betahistme in the inner of the guinea pig//Eur Arch Otorhmolaringolol// 1998,- 255.-P. 119-123.
  73. Norris C.H. Drugs affecting the in ner ear // Drugs. - 1988. - Vol. 36. - P. 754-772.
  74. Oosterveld W. J. Betahistine dihydrochlonde in the treatment of vertigo of peripheral vestibular origin. A doubleblmd placebocontrolled study//J. Laryngol. Otol. - 1984. -Vol. 98. - P. 37-41.
  75. Oosterveld W.J. Current diagnostic techniques in vestibular disorders // Acta Otolaryngol (Stockh). - 1991. - Vol. 479 (Suppl.). - P. 29-34.
  76. Oosterveld W.J. Effect of betahistme dihydrochloride on induced vestibular nystagmus: a doubleblmd study // Clin. Otolaryngol. -1987.-Vol. 12.-P. 131-135.
  77. Oosterveld W.J. Vertigo Current concepts in management. Drugs.- 1985. -Vol. 30. - P. 275-283.
  78. Oosterveld W.J., Blijieven W., van Elferen L.W.M. Betahistine versus placebo in paroxysmal vertigo: a doubleblmd trial // J. Drug. Ther. Res. - 1989. -Vol. 14. - P.4. - 122-126.
  79. Ottosson A., Jansen I., Edvmsson L. Characterisation of histamme receptors in isolated human cerebral arteries // Br. J. Pharmacol. -1988.-Vol. 94.-P. 901-907.
  80. Pathy J., Menon G., Reynolds A., van Strik R. Betahistme hydrochlonde (Sere) in cerebrovascular disease: a placebocontrolled study//Age Ageing. - 1977. -Vol. 6. - P. 179-184
  81. Pfaltz C.R., Aoyagi M.,Calcium entry blockers in the treatment of vestibular disoders. Acta Otolaryngol. 1988; Suppl. 460; P. 135142.
  82. Prell G.D., Green J.P. Histamme as a neuroregulator // Annu Rev. Neurosci. - 1986. - Vol. 9. - P. 209-254.
  83. Rivera V.M., Meyer J.S., Baer RE. et al. Vertebrobasilar arterial insufficiency with dementia: controlled trials of treatment with betahistme dihydrochloride //J. Am. Genatr. Soc. - 1974'. -Vol. 22.- P. 397-406.
  84. Rubm W. Vestibular suppressant drugs //Arch. Otolaryngol. - 1973.-Vol. 97.-P. 135-138.
  85. SS.Rudge P. The Eighth Cranial Nerve / In: Weatherall D.J., Ledingham J G.G , Warrell D.A. "Oxford Textbook of Medicine", 2nd Ed. -% Oxford University Press, 1988. - P. 21.92.
  86. Schuknecht H.F., Gulya A.J. Endolymphatic hydrops - an overview of classification // Ann. Otol. Rhmol. Laryngol. - 1983. - Vol. 106 (Suppl.).-P. 1-20.
  87. Schwartz J.C. H3 receptors control histamme release in the Human brain//J. Neurochem. - 1988. -Vol.51. -P. 105-108.
  88. SS.Shambaugh G.Jr, Wier R. The diagnosis and evaluation of allergic disorders with food intolerance in Meniere's disease // ORL Clin. N. Amer. - 1980. -Vol. 13. - P. 671.
  89. Sheldon C.H., Horton B.T. Treatment of Meniere's disease with histamme administered mtrave nously// Proc. Staff. Meet. Mayo Clin.-1940.-Vol. 15.-P. 17-21.
  90. Sokoloff L. The action of drugs on the cerebral circulation // Pharmacol. Rev. - 1959. -Vol. 11. - P. 1-85.
  91. Stembusch H.W.M., MulderA.H. Immunohistochemical localization of histamine in neurons and mast cells in the rat brain/In: "Handbook of chemical neuroanatomy". A.Bjorklund, T.Hokfelt, M.J.Kuhar (Eds).Vol 3. Classical transmitters and transmitter receptors in the CNS. -Amsterdam: Elsevier Science Publishers, 1984. -Vol. 126-140.
  92. Stephen P.J., Williamson J. Drugmduced parkinsonism in the elderly//Lancet. - 1984. -Vol. ii. -P. 1082-1083.
  93. Stough A.R. A tolerance study of betahistme dihydrochloride // Curr. Ther. Res. - 1963.-Vol. 5 (Suppl. 10). -P. 542-549.
  94. Suga F, Snow J.B. Cochlear blood flow in response to vasodilatmg drugs and some related agents // Laryngoscope. - 1969. - Vol. 79.-P. 1956-1979.
  95. The Impact on the Budget of the Regie de I assurance maladie du Quebec. Betaserc (betahistine dihydroclonde).
  96. Thornton A.R.D., Farrell G., Haacke N.R. A nonmvasive, objective test of endolymphatic hydrops // Acta Otolaryngol. (Stockh.). -1991. -Vol. (Suppl. 479). - R 35-43.
  97. Tighilet В., Leonard J., Lacour M. Betahistme dihydrochloride treatment facilitates vestibular compensation in the cat // J. Vestib. Res.- 1995. -Vol. 5. -P. 53-66.
  98. Timmerman H. Histamme agonists and antagonists // Acta Otolaryngol. (Stockh.). - 1991. - Vol. 479 (Suppl.). -P. 5-11.
  99. Timmerman H. Pharmacotherapy of vertigo: any news to be expected? // Acta Otolaryngol. (Stockh.). - 1994. - Vol. 513 (Suppl.). - P. 28-32.
  100. Tomita M., Gotoh F, Sato T. et al. Comparative responses of the carotid and vertebral arterial systems of rhesus monkeys to betahistme//Stroke. - 1978. -Vol.9. - P. 382-387.
  101. Tran Ba Huy P., Meyrand M.F. Le dichlorhydrate de betahistine en 2 prises ou en 3 prises par jour //J. Fr. OtoRhinoLaryngol. - 1992. -Vol.41 (Suppl. 3). -P. 1-4.
  102. Unemoto M, Sasa M., Takaon S. et al. Inhibitory effect of betahistme on polysynaptic neurons in the lateral vestibular nucleus // Arch. Otorhmolaryngol. - 1982. - Vol. 236. - P. 229-236.
  103. Valh P., Guth P.S., Perm P., Norris С. Н. The vestibular hair cells: post-trans-ductional signal processing// Prog-Neurobiol, -1998.-54.-P. 193-247.
  104. Van Cauwenberge P.B., De Moor S.E.G. Physiopathology of HSreceptors and pharmacology of betahistine// Acta Otolaryngol. (Stokh). 1997. Suppl. 526. P. 4346.
  105. Van der Schoot J.B. Disposition studies of betahistine dihydrochloride. Part 2: Excretion and plasma level sludies in man. - Data on file, Report No. 56654/17/79 (1976).
  106. WatanabeT, Taguchi Y., Shiosaka S. et al. Distribution of the hist-ammergic neuron system in the central nervous system of rats: a fluorescent Immunohistochemical analysis with histidme decar-boxylase as a marker//Brain Res. - 1984. -Vol. 295. - P. 13-25.
  107. Wilmot T.J. An objective study of the effect of betahistme hydrochlonde on hearing and vestibular function tests in patients with Meniere's disease //J. Laryngol. Otol. - 1971. -Vol. 85. - P. 369-373.
  108. WilmotT.J. Meniere's disorder//Clin. Otolaryngol. - 1979. -Vol. 4.-P. 131-143.
  109. Wilmot T.J., Menon G.N. Betahistine in Meniere's disease // J. Laryngol. Otol. - 1976. - Vol. 90. - P. 833-840.
  110. Wilson W.H. Intravenous and optimumdosage histamine therapy in Meniere's disease // Arch. Otolaryngol. - 1973. - Vol. 97. - P. 139-141.
  111. m.Yabe T, de Waele C., Serafm M. et al. II. An in vivo study // Exp Brain Res. - 1993.. -Vol. 93. - P. 249-258.



Solvay Pharma Реклама: Прививки защитят Вас и Вашу семью от гриппа
Баннерная сеть Солвей-Фарма.ру
Адрес


Последнее обновление  27.12.2008 г.